Centogene - 53 Year Dividend History | CNTGF
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Information Systems | $0.000B | $0.053B |
Centogene is a commercial-stage company focused on rare diseases that transforms real-world clinical and genetic data into actionable information for patients, physicians and pharmaceutical companies. The Company?s goal is to bring rationality to treatment decisions and to accelerate the development of new orphan drugs by using their knowledge of the global rare disease market, including epidemiological and clinical data and innovative biomarkers. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Veeva Systems (VEEV) | United States | $46.738B | 59.46 |
Hims & Hers Health (HIMS) | United States | $12.987B | 134.93 |
Doximity (DOCS) | United States | $11.457B | 53.04 |
Tempus AI (TEM) | United States | $11.228B | 0.00 |
IRhythm Technologies (IRTC) | United States | $4.298B | 0.00 |
Inspire Medical Systems (INSP) | United States | $3.880B | 60.62 |
Hinge Health (HNGE) | United States | $3.671B | 0.00 |
Privia Health (PRVA) | United States | $2.475B | 169.17 |
Clover Health Investments (CLOV) | United States | $1.735B | 0.00 |
Schrodinger (SDGR) | United States | $1.690B | 0.00 |
10x Genomics (TXG) | United States | $1.677B | 0.00 |
Phreesia (PHR) | United States | $1.648B | 0.00 |
Enovis (ENOV) | United States | $1.582B | 8.82 |
Azenta (AZTA) | United States | $1.578B | 73.36 |
Omnicell (OMCL) | United States | $1.321B | 23.31 |
Evolent Health (EVH) | United States | $1.199B | 102.10 |
Claritev (CTEV) | United States | $0.719B | 0.00 |
Fulgent Genetics (FLGT) | United States | $0.575B | 0.00 |
Standard BioTools (LAB) | United States | $0.551B | 0.00 |
Butterfly Network (BFLY) | United States | $0.532B | 0.00 |
Veradigm (MDRX) | United States | $0.503B | 0.00 |
Talkspace (TALK) | United States | $0.438B | 131.00 |
TruBridge (TBRG) | United States | $0.347B | 770.33 |
Outset Medical (OM) | United States | $0.345B | 0.00 |
Health Catalyst (HCAT) | United States | $0.282B | 0.00 |
Nyxoah SA (NYXH) | Belgium | $0.265B | 0.00 |
SOPHiA GENETICS SA (SOPH) | Switzerland | $0.241B | 0.00 |
CapsoVision (CV) | United States | $0.197B | 0.00 |
Zepp Health (ZEPP) | Netherlands | $0.176B | 0.00 |
KORU Medical Systems (KRMD) | United States | $0.164B | 0.00 |
Pulmonx (LUNG) | United States | $0.152B | 0.00 |
American Well (AMWL) | United States | $0.134B | 0.00 |
MDxHealth SA (MDXH) | Belgium | $0.122B | 0.00 |
EUDA Health Holdings (EUDA) | Singapore | $0.115B | 0.00 |
CareCloud (CCLD) | United States | $0.105B | 3.98 |
Insight Molecular Diagnostics (IMDX) | United States | $0.086B | 0.00 |
ImmunoPrecise Antibodies (IPA) | Canada | $0.083B | 0.00 |
111 (YI) | China | $0.064B | 0.00 |
P3 Health Partners (PIII) | United States | $0.053B | 0.00 |
HeartBeam (BEAT) | United States | $0.043B | 0.00 |
Zhongchao (ZCMD) | China | $0.026B | 0.00 |
Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
Precipio (PRPO) | United States | $0.022B | 0.00 |
Bullfrog AI Holdings (BFRG) | United States | $0.015B | 0.00 |
Healthcare Triangle (HCTI) | United States | $0.010B | 0.00 |
Strata Skin Sciences (SSKN) | United States | $0.009B | 0.00 |
MSP Recovery (MSPR) | United States | $0.008B | 0.00 |
Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
Movano (MOVE) | United States | $0.005B | 0.00 |
HeartSciences (HSCS) | United States | $0.004B | 0.00 |
Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
Mobile-health Network Solutions (MNDR) | Singapore | $0.003B | 0.00 |
Future Health ESG (FHLT) | United States | $0.000B | 0.00 |